News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
124 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
2 (104)
3 (173)
4 (173)
5 (128)
6 (1)
7 (23)
8 (258)
9 (151)
10 (98)
11 (90)
12 (52)
13 (1)
14 (1)
15 (70)
16 (158)
17 (130)
18 (132)
19 (69)
20 (4)
21 (3)
22 (130)
23 (153)
24 (124)
25 (141)
26 (79)
27 (1)
28 (1)
29 (133)
30 (155)
31 (147)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Business
Incyte to Report Fourth Quarter and Year-End Financial Results
Incyte announced today that it has scheduled its fourth quarter and year end 2017 financial results conference call and webcast for 10:00 a.m. ET on Thursday, February 15, 2018.
January 24, 2018
·
1 min read
Drug Development
Apexian Pharmaceuticals Opens Phase I Clinical Study of APX3330 in Patients with Solid Tumors
The study involves APX3330, a first in class orally administered inhibitor of APE1/Ref 1, a dual-function protein that plays a critical role in promoting and maintaining a broad variety of cancers.
January 24, 2018
·
2 min read
Business
Precision NanoSystems Technology Included in Newly Opened Non-Coding RNA Precision Diagnostics and Therapeutics Core Facility
This new facility is dedicated to the study of ncRNA, which play an important role in regulating gene expression and are important for understanding, detecting, and treating disease.
January 24, 2018
·
2 min read
BioMidwest
Linear Health Sciences Announces Issuance of First U.S. Patent
Linear Health Sciences today announced that the United States Patent and Trademark Office has issued the company’s first patent related to its flagship product, the Orchid Safety Release Valve.
January 24, 2018
·
2 min read
BioMidwest
Panasonic Healthcare Corporation of North America Release: New -86˚C Slim Profile Upright Freezer Added to Award-Winning TwinGuard® Series, Includes Dual Cooling System, Installs in Tight Spaces
The new model is designed and extensively field-tested to protect specimen viability and security vital to long-term preservation of high-value biological samples in life science, biobanking, pharmaceutical and biotechnology.
January 24, 2018
·
5 min read
Business
BioMarin to Host Fourth Quarter and Full Year 2017 Financial Results Conference Call and Webcast on Thursday, February 22 at 4:30pm ET
BioMarin today announced that Jean-Jacques Bienaimé, Chairman and CEO of BioMarin, will host a conference call and webcast on Thursday, February 22, at 4:30 p.m. ET to discuss fourth quarter and full year 2017 financial results and provide a general business update.
January 24, 2018
·
1 min read
Gecko Biomedical Secures €6 Million in Funding under the Investments for the Future Programme (Programme d’investissements d’avenir, PIA), to Industrialize and Develop Innovative Solutions for Tissue Reconstruction
This funding is a contribution towards the industrialization and development of innovative solutions in the area of tissue reconstruction, and the peripheral nerve in particular.
January 24, 2018
·
6 min read
Biotech Bay
Digital Pathology Extending Through UK as OptraSCAN Welcomes First On-Demand UK Customer
OptraSCAN, Inc. announced its first UK-based customer NHS Trust Plymouth Hospital, Derriford. Derriford Hospital plans to utilize digital pathology for routine research and training of professionals in the field of pathology and digital platforms.
January 24, 2018
·
3 min read
Policy
Bioatla Announces FDA Clearance of IND Application for CAB-AXL-ADC Therapeutic
BioAtla announced today the FDA has cleared BioAtla’s IND for BA3011, a novel conditionally active AXL-targeted antibody-drug conjugate, in patients with solid tumors.
January 24, 2018
·
3 min read
Biotech Beach
Mesa Biotech Obtains CE Mark for its Accula Point of Care Testing System
The first available test in the EU market will be the company’s Flu A/Flu B Test.
January 24, 2018
·
3 min read
Previous
2 of 13
Next